Digital Lifestyle Coaching for Alzheimer's Disease
(WellderlyBrain Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if digital lifestyle coaching can improve blood markers linked to Alzheimer's disease in adults with a higher genetic risk for the condition. Participants will use an app for coaching over a year and provide blood and saliva samples for analysis. It targets individuals aged 60 to 80 who are part of 23andMe research, possess a specific genetic marker (APOE4), and can use a smartphone. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to new preventive strategies for Alzheimer's disease.
What prior data suggests that this digital lifestyle coaching is safe for participants?
Research has shown that digital lifestyle coaching is generally safe and well-received by participants. Studies have found that these programs can lead to positive results without major side effects. The focus on lifestyle changes, such as exercise and diet, usually involves minimal risk. Participants often report high satisfaction and find these programs easy to follow and helpful.
Since this trial tests a lifestyle approach rather than a new drug, the risks remain low. Participants engage in activities like virtual coaching sessions, which are unlikely to cause harm. Overall, previous research supports the safety of digital lifestyle programs in similar situations.
Why are researchers excited about this trial?
Unlike the standard care options for Alzheimer's, which often include medications like donepezil or memantine, Digital Lifestyle Coaching offers a fresh approach by focusing on behavior and lifestyle changes through virtual coaching. Researchers are excited about this method because it leverages technology to deliver personalized guidance, potentially improving cognitive health by encouraging healthier daily habits. This approach not only empowers patients by giving them active roles in managing their condition but also promises a more engaging and accessible way to complement traditional treatments.
What evidence suggests that digital lifestyle coaching is effective for Alzheimer's disease?
Research has shown that digital lifestyle coaching might help reduce the risk of Alzheimer's disease. In this trial, participants will receive either Virtual Lifestyle Coaching or Standard of Care. Studies have found that personalized coaching can slow memory and thinking problems more effectively than standard treatment alone. For instance, health coaching has been linked to lower risks of other health issues like diabetes, which can affect Alzheimer's risk. Additionally, digital health coaching may improve brain function and reduce the chance of developing dementia. Overall, these findings suggest that digital lifestyle coaching could be useful in addressing factors that increase the risk of Alzheimer's disease.12345
Who Is on the Research Team?
Eric J Topol, MD
Principal Investigator
Scripps Translational Research Institute
Are You a Good Fit for This Trial?
This trial is for adults aged 60-80 in the US who have a genetic risk for Alzheimer's (APOE4 or high polygenic risk), are current 23andMe research participants, own a smartphone, and can do at-home saliva and finger-prick blood tests.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a virtually delivered, multidomain lifestyle coaching intervention over 52 weeks
Monitoring
Continuous health monitoring via Oura Ring and collection of dried blood samples at baseline, 6 months, and 12 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Digital Lifestyle Coaching
Trial Overview
The study compares digital lifestyle coaching sessions to education-only materials to see if virtual coaching helps reduce Alzheimer’s disease markers in the blood. Participants are randomly assigned to one of these two groups and monitored over about 14-16 months.
How Is the Trial Designed?
2
Treatment groups
Active Control
Participants will receive an Oura Ring with daily metrics of sleep and activity but no supplemental education of guidance on improving their scores. They will have access to current standard of care worksheets.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Scripps Translational Science Institute
Lead Sponsor
23andMe, Inc.
Industry Sponsor
Alamar Biosciences
Collaborator
Oura Ring, Inc
Collaborator
Sapient Bioanalytics
Collaborator
TEAL Rise
Collaborator
Citations
Digital Lifestyle Coaching for Alzheimer's Disease ...
Wellderly Brain is a randomized, direct-to-participant trial evaluating whether a virtually delivered, multidomain lifestyle coaching ...
Face-to-Face and Digital Multidomain Lifestyle Interventions to ...
The primary outcome measure will be Alzheimer's Disease risk factor, calculated using the shortened version of the Australian National University – Alzheimer's ...
The effect of a digital health coaching and health education ...
These results indicate that HC and HE can both improve cognition, but HC may be more effective and may yield increased protection against ADRD risk.
4.
isbscience.org
isbscience.org/news/health/personalized-coaching-decreases-cognitive-decline-in-early-stage-alzheimers-disease-patients/Personalized Coaching Decreases Cognitive Decline in ...
Personalized lifestyle coaching leads to less cognitive decline compared to standard of treatment alone, according to an ISB-led two-year study.
Initial Perspectives From Rural-Residing Adults on a Digital ...
Specifically, health coaching interventions have been linked to decreased risk of Alzheimer disease (AD) comorbidities, such as diabetes.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.